It would be interesting to investigate whether an altered distribution of intratumoral CD8+ T cells between these populations with aging or obesity could contribute to the observed paradox of reduced baseline anti-tumor immunity with intact ICB responses. This evidence concerns the gene CD8A and neoplasm.